Lowering the risk of leukemia
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Most leukemia is not caused by anything the person did or was exposed to. It arises from random errors made while blood stem cells copy their DNA, which happens constantly and occasionally lands in the wrong place.
That is the most important sentence on this page, particularly for parents of children with leukemia, who search exhaustively for a cause that in almost every case does not exist. What follows is the genuinely modifiable part, which is real but small.
Related pages: Leukemia (blood cancer)
The bottom line
- Benzene is an established cause of acute myeloid leukemia.
- Smoking increases the risk of AML.
- Some chemotherapy and radiation treatments cause secondary leukemia years later.
- There is no screening test for leukemia in people without symptoms.
- Whether low-dose radiation from diagnostic imaging causes any measurable number of leukemias, which is extrapolated rather than observed.
- What causes the great majority of childhood leukemia, where the infection-timing hypothesis is the leading idea and is not proven.
The story, step by step
What the evidence labels mean
Benzene and occupational exposure
What happens
The clearest avoidable cause.
What the research shows
- Benzene is an established human carcinogen and the link to acute myeloid leukemia is one of the best-documented in occupational medicine.
- Exposure matters most at work: petroleum refining and distribution, chemical manufacturing, rubber and shoe production, painting, printing and some laboratory work.
- Protection means engineering controls and ventilation first, respiratory and skin protection where required, and exposure monitoring. Workplace limits exist and are enforceable.
- Everyday exposure is far lower. Filling a car releases benzene vapour, which is a reason not to linger over the nozzle, not a reason for alarm.
- Formaldehyde and some pesticides have been associated with myeloid leukemias in occupational studies, though the evidence is weaker and less consistent than for benzene.
- Cigarette smoke contains benzene, which is part of why smoking raises AML risk. Stopping lowers it over time.
Why it matters
If you work with solvents or fuels, this is the part of the page that applies to you, and the controls are a legal duty of the employer rather than a personal precaution.
What's still uncertain
- The risk at low-level, long-term exposure below occupational limits, which is extrapolated downward from high-exposure studies.
Read more
- CDC: BenzeneGovernment
- NIOSH: Occupational cancer and chemical carcinogensGovernment
- National Cancer Institute: Risk factors for cancerGovernment
Next: Radiation
What counts, and what doesn't
What happens
Keeping dose in proportion.
What the research shows
- High-dose ionizing radiation causes leukemia. The evidence comes from atomic bomb survivors, from radiotherapy, and from early radiation workers.
- Diagnostic imaging doses are far lower. A CT scan carries a small theoretical risk estimated by extrapolating from those high-dose studies, and has not been observed directly at that level.
- The practical advice is to avoid unnecessary scans and to ask whether ultrasound or MRI would answer the question, while not refusing imaging that is needed. A missed diagnosis is a certain harm; the radiation risk is a small probabilistic one.
- Radon in homes causes lung cancer; its link to leukemia is weak and inconsistent. Testing for radon is still worthwhile for the lung cancer reason.
- Non-ionizing sources, including mobile phones, Wi-Fi and household electrical devices, do not cause leukemia. Power line magnetic fields have been studied extensively for childhood leukemia, with a weak statistical association that has never been explained by any mechanism and is widely regarded as unlikely to be causal.
- Medical radiotherapy for a previous cancer does carry a real risk of later leukemia, which oncologists weigh when planning treatment.
Why it matters
The clear risks are at doses most people will never encounter. The unclear ones are mostly in the category of studied repeatedly and never confirmed.
What's still uncertain
- Whether any excess leukemia results from diagnostic imaging at current doses, which existing studies cannot resolve.
Read more
- National Cancer Institute: Risk factors for cancerGovernment
- National Cancer Institute: LeukemiaGovernment
- MedlinePlus: LeukemiaGovernment
Next: Treatment
Secondary leukemia
What happens
The risk that comes from curing something else.
What the research shows
- Alkylating chemotherapy agents and topoisomerase II inhibitors can damage surviving blood stem cells and cause a later myeloid leukemia or myelodysplastic syndrome.
- Alkylator-related cases typically appear 5 to 10 years afterwards; topoisomerase-related cases appear earlier, often within 1 to 3 years, with a distinctive genetic signature.
- The absolute risk is low and is weighed against the benefit of treating the original cancer, which is usually far larger.
- Radiotherapy, particularly to large volumes of marrow, adds to the risk.
- This is one of the reasons survivorship follow-up continues for years: unexplained fatigue, bruising or falling blood counts in someone treated for a previous cancer are investigated rather than assumed to be age.
- Clonal hematopoiesis, where a blood stem cell with a mutation expands without causing disease, is common with age and is more likely to progress after chemotherapy. It is increasingly recognized and is a research area rather than something routinely tested for.
Why it matters
This is a reason for follow-up and for honest consent conversations, not a reason to decline cancer treatment.
What's still uncertain
- How to identify which patients with clonal hematopoiesis will progress, and whether anything can prevent it.
Read more
- National Cancer Institute: Risk factors for cancerGovernment
- National Cancer Institute: LeukemiaGovernment
- National Cancer Institute: Survivorship and late effectsGovernment
Next: Inherited
Syndromes, families, and who is monitored
What happens
The small but important genetic share.
What the research shows
- A minority of leukemias occur in people with inherited conditions that carry higher baseline risk: Down syndrome, Fanconi anemia, Bloom syndrome, ataxia-telangiectasia, Li-Fraumeni syndrome, Klinefelter syndrome, and inherited bone marrow failure syndromes.
- Familial clustering of myeloid malignancy exists, including germline mutations in genes such as RUNX1, GATA2, DDX41 and CEBPA. These are now looked for more often, particularly in younger patients and where there is a family history.
- It matters practically for transplant: a family member being considered as a donor is tested, because donating marrow that carries the same predisposition defeats the purpose.
- People with a known predisposition syndrome are followed with regular blood counts and prompt assessment of unexplained symptoms.
- Having a relative with leukemia slightly raises risk and in most families does not indicate an inherited syndrome. Genetic counselling is the route to knowing which situation you are in.
- Leukemia itself is not contagious and is not passed on like an infection.
Why it matters
For most families the useful answer is that no screening is recommended and no action is needed. For a small number, knowing changes donor choice and monitoring.
What's still uncertain
- How many apparently sporadic leukemias have an unrecognized germline predisposition, which current studies suggest is higher than once thought.
Read more
- National Cancer Institute: Risk factors for cancerGovernment
- National Cancer Institute: LeukemiaGovernment
- MedlinePlus: LeukemiaGovernment
Next: Honest limits
What does not prevent leukemia
What happens
Where the claims outrun the evidence.
What the research shows
- There is no screening test for leukemia in people without symptoms. A routine blood count is not recommended as screening in the general population, and most leukemias found on a blood test are found incidentally.
- No diet, supplement, detox or alkaline regimen prevents leukemia. Sleep, exercise and nutrition support general health and have not been shown to reduce leukemia risk specifically; claims that they boost immune surveillance against leukemia are not supported.
- Obesity has been associated with a modestly higher risk of some myeloid leukemias in large cohort studies, which is one of the few lifestyle associations with reasonable support.
- For childhood leukemia in particular, no parental exposure, vaccine, food or household factor has been established as a cause. The leading scientific idea, the delayed infection hypothesis, proposes that an immune system with little early microbial exposure responds abnormally to a later common infection. It is a hypothesis with supporting evidence, not a settled explanation.
- What early recognition can do is matter a great deal: persistent unexplained fatigue, repeated fevers, unexplained bruising or pinpoint red spots, bone pain, night sweats or swollen lymph nodes deserve a blood count rather than a wait.
Why it matters
The honest position is that most leukemia cannot currently be prevented. Saying otherwise shifts blame onto people who did nothing wrong.
What's still uncertain
- What drives the great majority of cases, which remains unknown.
Read more
- National Cancer Institute: Risk factors for cancerGovernment
- National Cancer Institute: LeukemiaGovernment
- MedlinePlus: LeukemiaGovernment